COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA

por Hanania, Nicola A, Bunner, Scott H, Bengtson, Lindsay G S, Ismaila, Afisi S, Bogart, Michael
Publicado 2023

Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer

por Engel-Nitz, Nicole M., Johnson, Michael P., Bunner, Scott H., Ryan, Kellie J.
Publicado 2020

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

por Simmons, Daniel, Blank, Stephanie V., ElNaggar, Adam C., Chastek, Benjamin, Bunner, Scott H., McLaurin, Kimmie
Publicado 2022